Guillermo Riestra
Foot & Ankle Surgery · Elizabeth, NJNPI 1356087860
Payments from drug & device makers
Across 65 payments — averaging $74.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medline Industries LP$2K
- Stryker$2K
- Kerecis Limited$617
- Amgen$347
- Integra Lifesciences Corporation$165
- Tactile Systems Technology Inc$57
- plus $126 from 5 others
What the payments were for
- Travel & lodging$2,00442%
- Food & beverage$2,81758%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medline Industries LP | 8 | $1,779 |
| Stryker | 22 | $1,730 |
| Kerecis Limited | 9 | $617 |
| Amgen | 15 | $347 |
| Integra Lifesciences Corporation | 2 | $165 |
| Tactile Systems Technology Inc | 2 | $57 |
| Dynasplint Systems Inc. | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 2 | $32 |
| Organogenesis Inc. | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Treace Medical Concepts, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$1,652
- ORTHOLOC 3DI$607
- Kerecis GraftGuide$413
- AUGMENT INJECTABLE$328
- INBONE$169
- KRYSTEXXA$124
How this compares
$4,820 in reported general payments places this provider in the 70th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 28 | $1,253 |
| Ammonium Lactate | 58 | $1,207 |
| Clotrimazole | 11 | $146 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Elizabeth
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.